Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Montelukast 10 mg Tablets vs Singulair 10 mg in Healthy Thai Volunteers (Fasting, Single-Dose, Two-Way Crossover)
TCTR20180614001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of montelukast in asthma and allergic rhinitis (AR) (2 arms), sponsored by International Bio Service. Planned start Jul 2018; status: not yet recruiting.
02
Drugs
montelukast
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on TCTR20180614001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180614001.